These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 18178197

  • 1. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
    Orvieto R, Meltzer S, Rabinson J, Zohav E, Anteby EY, Nahum R.
    Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
    [Abstract] [Full Text] [Related]

  • 2. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome.
    Rabinson J, Meltcer S, Zohav E, Gemer O, Anteby EY, Orvieto R.
    Fertil Steril; 2008 Feb; 89(2):472-4. PubMed ID: 17582402
    [Abstract] [Full Text] [Related]

  • 3. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
    Orvieto R, Meltzer S, Rabinson J, Gemer O, Anteby EY, Nahum R.
    Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects.
    Haouzi D, Assou S, Dechanet C, Anahory T, Dechaud H, De Vos J, Hamamah S.
    Biol Reprod; 2010 Apr; 82(4):679-86. PubMed ID: 20042535
    [Abstract] [Full Text] [Related]

  • 6. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
    Orvieto R, Nahum R, Meltzer S, Liberty G, Anteby EY, Zohav E.
    Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
    [Abstract] [Full Text] [Related]

  • 7. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A.
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [Abstract] [Full Text] [Related]

  • 8. Detrimental effects of high-dose gonadotropin on outcome of IVF: making a case for gentle ovarian stimulation strategies.
    Kovacs P, Sajgo A, Kaali SG, Pal L.
    Reprod Sci; 2012 Jul; 19(7):718-24. PubMed ID: 22378863
    [Abstract] [Full Text] [Related]

  • 9. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
    Orvieto R, Rabinson J, Meltcer S, Gemer O, Anteby EY, Zohav E.
    Fertil Steril; 2008 Mar; 89(3):736-7. PubMed ID: 17498708
    [Abstract] [Full Text] [Related]

  • 10. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R, Nahum R, Zohav E, Liberty G, Anteby EY, Meltcer S.
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [Abstract] [Full Text] [Related]

  • 11. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer].
    Ma QH, Li SW, Huang ZY, Han ZY, Qiu DS, Han DW.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of mild stimulation and conventional stimulation in ART outcome.
    Karimzadeh MA, Ahmadi S, Oskouian H, Rahmani E.
    Arch Gynecol Obstet; 2010 Apr; 281(4):741-6. PubMed ID: 19834718
    [Abstract] [Full Text] [Related]

  • 15. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H, Devroey P.
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [Abstract] [Full Text] [Related]

  • 16. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK.
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [Abstract] [Full Text] [Related]

  • 17. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity.
    Devroey P, Bourgain C, Macklon NS, Fauser BC.
    Trends Endocrinol Metab; 2004 Mar; 15(2):84-90. PubMed ID: 15036255
    [Abstract] [Full Text] [Related]

  • 18. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
    Martínez F, Rodríguez DB, Buxaderas R, Tur R, Mancini F, Coroleu B.
    Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
    De Placido G, Mollo A, Clarizia R, Strina I, Conforti S, Alviggi C.
    Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
    [Abstract] [Full Text] [Related]

  • 20. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S.
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.